We are pleased to announce details of our next 'C-Suite Breakfast Discussion', kindly hosted by EY on 4 June. This session will address and consider exit strategy options for R&D SME's, more specifically: 'IPO to Exit Readiness: Seamlessly Navigating Transitions for Value Growth'

Almost every growing business reaches a point in its life cycle when stakeholders need to decide whether to introduce new capital to fund the next stage in its evolution (and potentially enable shareholders to sell some of their stake) or to undertake a sale process that results in a full exit for shareholders and new ownership to take the business forward. Join us as we discuss how to prepare for both IPO and M&A processes and explore some of the key similarities and differences.



Programme:

08.30 Guest arrival, breakfast and networking

09.00 Welcome by OBN

09.05 Keynotes from

• Laura Letts​, Partner, EY
• Laura Segert​, Partner, EY
• James Foster​, Partner, Mills & Reeve

09.30 Round table discussion between all guests

10.30 Event close

Event format: OBN's round table C-Suite Discussions are designed exclusively for senior leaders (C-Suite or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry. The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.

Please note that places are limited and will be offered on an approval only basis. Complimentary tickets available for OBN Members & Academics, non-OBN Member tickets available at £75.00 plus VAT.